List of Critical Outcome Technologies, Inc. patents

List of Critical Outcome Technologies, Inc. patents

List of Bemis Manufacturing Company patents

List of OSENSE TECHNOLOGY CO., LTD. patents

List of Trifacta patents

List of NGOs in Norwich

List of funding rounds for ILIAD BIOTECHNOLOGIES, LLC

Patents where

Current Assignee

Name

is

‌

Critical Outcome Technologies, Inc.

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 7629347 Protein tyrosine kinase inhibitors	Patent 7629347 was granted and assigned to Critical Outcome Technologies, Inc. on December, 2009 by the United States Patent and Trademark Office.		‌ Critical Outcome Technologies, Inc.		United States Patent and Trademark Office	7629347	December 8, 2009
	‌ US Patent 9422282 Compounds and method for treatment of HIV	Patent 9422282 was granted and assigned to Critical Outcome Technologies, Inc. on August, 2016 by the United States Patent and Trademark Office.	‌ Critical Outcome Technologies, Inc.	‌ Critical Outcome Technologies, Inc.		United States Patent and Trademark Office	9422282	August 23, 2016
	‌ US Patent 8987272 Compounds and method for treatment of HIV	Patent 8987272 was granted and assigned to Critical Outcome Technologies, Inc. on March, 2015 by the United States Patent and Trademark Office.		‌ Critical Outcome Technologies, Inc.		United States Patent and Trademark Office	8987272	March 24, 2015
	‌ US Patent 9284275 Inhibitor compounds and cancer treatment methods	Patent 9284275 was granted and assigned to Critical Outcome Technologies, Inc. on March, 2016 by the United States Patent and Trademark Office.	‌ Critical Outcome Technologies, Inc.	‌ Critical Outcome Technologies, Inc.		United States Patent and Trademark Office	9284275	March 15, 2016
	‌ US Patent 9624220 Compounds and method for treatment of HIV	Patent 9624220 was granted and assigned to Critical Outcome Technologies, Inc. on April, 2017 by the United States Patent and Trademark Office.	‌ Critical Outcome Technologies, Inc.	‌ Critical Outcome Technologies, Inc.		United States Patent and Trademark Office	9624220	April 18, 2017
	‌ US Patent 8822475 Compounds and method for treatment of cancer	Patent 8822475 was granted and assigned to Critical Outcome Technologies, Inc. on September, 2014 by the United States Patent and Trademark Office.	‌ Critical Outcome Technologies, Inc.	‌ Critical Outcome Technologies, Inc.		United States Patent and Trademark Office	8822475	September 2, 2014
	‌ US Patent 8466151 Compounds and method for treatment of cancer	Patent 8466151 was granted and assigned to Critical Outcome Technologies, Inc. on June, 2013 by the United States Patent and Trademark Office.		‌ Critical Outcome Technologies, Inc.		United States Patent and Trademark Office	8466151	June 18, 2013
	‌ US Patent 8895556 Compounds and method for treatment of cancer		‌ Critical Outcome Technologies, Inc.	‌ Critical Outcome Technologies, Inc.		United States Patent and Trademark Office	8895556	November 25, 2014
	‌ US Patent 8138191 Inhibitor compounds and cancer treatment methods	Patent 8138191 was granted and assigned to Critical Outcome Technologies, Inc. on March, 2012 by the United States Patent and Trademark Office.		‌ Critical Outcome Technologies, Inc.		United States Patent and Trademark Office	8138191	March 20, 2012
	‌ US Patent 8580792 Inhibitor compounds and cancer treatment methods			‌ Critical Outcome Technologies, Inc.		United States Patent and Trademark Office	8580792	November 12, 2013

10 results

0 selected

10 results

0 selected